Sign In
Buy ENTA
$13.37
+0.710 (+5.61%)
At Close: Jun 22, 2026
Enanta Pharmaceuticals to Present at Upcoming Investor Conferences
07:01am, Tuesday, 02'nd Mar 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals to Present at Upcoming Investor Conferences
Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q1 2021 Results - Earnings Call Transcript
10:20pm, Monday, 08'th Feb 2021
Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q1 2021 Results - Earnings Call Transcript
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates
06:12pm, Monday, 08'th Feb 2021
Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of 50.00% and 19.26%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the sto
Recap: Enanta Pharmaceuticals Q1 Earnings
05:06pm, Monday, 08'th Feb 2021
Shares of Enanta Pharmaceuticals (NASDAQ:ENTA) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 163.08% year over year to ($0.41)
Earnings Preview: Enanta Pharmaceuticals
10:09am, Friday, 05'th Feb 2021
Enanta Pharmaceuticals (NASDAQ:ENTA) unveils its next round of earnings this Monday, February 08. Get prepared with Benzinga's ultimate preview for Enanta Pharmaceuticals's Q1 earnings.
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals to Provide Updates on its R&D Programs and Outlook for 2021 at the 39th Annual J.P. Morgan Healthcare Conference
Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q4 2020 Results - Earnings Call Transcript
10:30pm, Monday, 23'rd Nov 2020
Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q4 2020 Results - Earnings Call Transcript
Enanta Pharmaceuticals: Q4 Earnings Insights
04:19pm, Monday, 23'rd Nov 2020
Shares of Enanta Pharmaceuticals (NASDAQ:ENTA) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 431.82% over the past year to ($1
13 Of 56 Outstanding Dividend Stocks Stand Tall For November
08:18pm, Thursday, 22'nd Oct 2020
From May to July, Kiplinger Today listed five sets of dividend stocks sorted as favorites, super-safe, durable, centenarian, and MoPays.
AbbVie: Stock Will Break $100 Once Management And Market Are On Same Page (NYSE:ABBV)
11:41pm, Tuesday, 20'th Oct 2020
AbbVie stock looked to have strong momentum in July, but Q2 results triggered a slide from $100, to $84 at the the time of writing.
Fluree Open Sources Its Entire Web3 Data Platform
12:00am, Tuesday, 20'th Oct 2020
Fluree, a market leader in secure data management, is releasing its core source code under the AGPL open source license. Developers can now pull from
The Global Antiviral Drugs Market will grow by USD 43.37 bn during 2020-2024
5 High-Yield Stocks for 5%-Plus Dividend Payouts
09:16am, Friday, 16'th Oct 2020
Times have been tough lately for income investors, but these high-yield stocks whose dividends are safe remain worth a second look.
Buy AbbVie Before It Raises Dividends Again (NYSE:ABBV)
08:16am, Thursday, 15'th Oct 2020
AbbVie has multiple product launches in 2021 that will bring billions more in revenue. Strong free cash flow available for a dividend hike.
菲律宾土著社区现可通过SOURCE® Hydropanel技术从阳光和空气中获得可再生饮用水
12:00am, Wednesday, 14'th Oct 2020
(美国商业资讯)--SOURCE Global, PBC和保护国际(Conservation International)今天宣布他们的第三次成功合作，将为巴拉望黎刹Iraan的Binta’t Karis土著居民提供可持续�
